News Flash

Town News

Posted on: September 24, 2021

2021-09-24 COVID-19 Vaccination Update

Vaccine (JPG)

Good Evening,

This is First Selectman Vicki Tesoro with an important COVID-19 Vaccination update.

Today, the Centers for Disease Control and the Prevention’s Advisory Committee on Immunization Practices (ACIP) voted to recommend that a single dose of the Pfizer COVID-19 vaccine can be administered as a booster at least six months after completing the primary Pfizer vaccine series to individuals 65 and older as well as select individuals 18-64 who are at risk of severe illness from COVID-19. 

The Trumbull Health Department is now offering the Covid-19 Pfizer booster vaccine.

The booster is only available for: 

  • People who have completed the primary Pfizer vaccine series
  • Those 65 years old and older and residents in long term care settings
  • People aged 18+ with underlying medical conditions and
  • People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting. 

Boosters can only be given at least 6 months after the second vaccination.

Beginning Monday, September 27th you can call the Trumbull Health Department at 203-638-5230 to schedule an appointment. Please also visit the Trumbull Health Department Facebook page: https://www.facebook.com/TrumbullHealthDepartment

You will need to bring your vaccination card, photo ID and insurance card to your appointment.

The Connecticut Department of Public Health has also been working with vaccine providers across the state to be ready for this booster roll-out. Individuals who are eligible for the booster can also visit https://portal.ct.gov/Vaccine-Portal to locate a vaccination site. 

Persons who received Moderna or Johnson & Johnson vaccines for their primary doses are not included in the CDC recommendation at this time.  The Connecticut Department of Public Health expects to see the inclusion of these booster shots in future guidelines.

On Monday, 9/20/2021, Pfizer announced that a phase 2/3 trial has shown its Covid-19 vaccine is safe for children 5-11 years of age.  Pfizer will be submitting documentation to the FDA in the next few weeks.

The COVID-19 vaccines authorized in the United States continue to be remarkably effective in reducing the risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant. It is critical that unvaccinated and partially vaccinated people get their primary series of vaccines to further reduce the risk of COVID-19 and its more severe outcomes. Nearly all the cases of severe disease, hospitalization, and death continue to occur among those not yet vaccinated at all.

Please stay well and stay safe!

Thanks for listening.

Facebook Twitter Email